IL6 and hematocrit: IL-6 emerged as a specific biomarker for HT-associated DED in our study, a finding that aligns with the work of Luo et al., who demonstrated the critical role of IL-6 in triggering and sustaining inflammatory cascades in dry eye disease [26].